Clinical Trials Logo

Clinical Trial Summary

NBCA is a synthetic biodegradable cyanoacrylate basis glue, modified by the addition of a monomer with adhesive, hemostatic, and antiseptic properties. Its use requires a steep learning curve to control emulsification of the NBCA/lipiodol mixture, and injection, to avoid non-target embolization. The aim of this retrospective monocentric study was to evaluate safety and efficacy of use of NBCA as embolic agent in emergency setting.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06301919
Study type Observational
Source Centre Hospitalier Universitaire de Saint Etienne
Contact Rémi GRANGE, MD
Phone (0)477828963
Email remi.grange@chu-st-etienne.fr
Status Recruiting
Phase
Start date March 1, 2024
Completion date May 1, 2024